Among patients younger than 40 years with stage IA or IC ovarian cancer who underwent surgery, the percentage who received FSS vacillated greatly over time and did not demonstrate a clear trend (eFigure 8 in Supplement 1 ).
1
—
—
Among patients younger than 40 years with stage IA or IC ovarian cancer who underwent surgery, the percentage who received FSS vacillated greatly over time and did not demonstrate a clear trend (eFigure 8 in Supplement 1 ).